Ovarian cancer risk in postmenopausal women using estradiol–progestin therapy – a nationwide study Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Ovarian cancer risk in postmenopausal women using estradiol–progestin therapy – a nationwide study Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Monday, March 11, 2013

Ovarian cancer risk in postmenopausal women using estradiol–progestin therapy – a nationwide study

Conclusion The elevated risk of non-mucinous ovarian cancer in users of EPT ≥ 5 years does not depend on progestin type, mode or route of administration of EPT

Read More: http://informahealthcare.com/doi/abs/10.3109/13697137.2012.663818

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments ( Atom )